Ahmed Bashtar
About Ahmed Bashtar
Ahmed Bashtar is the MEA Quality Unit Lead at Bristol Myers Squibb in Dubai, with extensive experience in quality assurance and compliance across multiple pharmaceutical companies.
Current Role at Bristol Myers Squibb
Ahmed Bashtar currently holds the position of MEA Quality Unit Lead at Bristol Myers Squibb, based in Dubai, United Arab Emirates. In his role, he oversees quality management practices across the region, ensuring compliance with international standards. His responsibilities include leading quality assurance initiatives and managing regulatory compliance for the organization's operations.
Previous Experience at Julphar
From 2019 to 2021, Ahmed Bashtar worked as the Regional QA Compliance Head at Julphar in the United Arab Emirates. During his tenure, he was responsible for overseeing quality assurance and regulatory compliance on a regional scale. His role included the management of quality systems, supplier quality management, and compliance auditing.
Quality Assurance Manager at Pfizer
Ahmed Bashtar served as a Quality Assurance Manager at Pfizer from 2016 to 2018. In this position, he was responsible for ensuring the quality and compliance of Pfizer's products and processes. His duties included the implementation of Good Manufacturing Practices (GMP) and conducting internal and supplier audits to maintain high standards of quality.
Education and Certification
Ahmed Bashtar holds a Master of Business Administration (MBA) from the University of Berlin, specializing in business administration and global economics. He also has a Master's degree in Quality Management from the Quality and Productivity Institute. Additionally, he has a Bachelor's degree in Pharmaceutical Sciences from the Faculty of Pharmacy, Cairo University. He is certified as a black belt and green belt in Six Sigma and is a certified auditor by GlaxoSmithKline.
Professional Expertise and Projects
Throughout his career, Ahmed Bashtar has demonstrated extensive expertise in quality management and regulatory compliance. He has led the implementation of Good Pharmacovigilance Practices (GVP), Good Clinical Practices (GCP), Good Distribution Practices (GDP), and Good Manufacturing Practices (GMP). His experience includes conducting compliance audits, managing supplier quality, and leading projects to enhance product quality and quality systems. His analytical skills and strategic approach have contributed to significant improvements in inventory control and overall quality management.